Valuation: Proteome Sciences plc

Market Cap 43.14L 56.69L 51.7L 47.8L 81.25L 53Cr 84.45L 5.77Cr 2.28Cr 29Cr 2.13Cr 2.08Cr 90Cr P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 1.93Cr 2.54Cr 2.31Cr 2.14Cr 3.64Cr 237.03Cr 3.78Cr 26Cr 10Cr 127.94Cr 9.52Cr 9.32Cr 404Cr EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day-14.65%
1 week-18.93%
Current month-27.85%
1 month-27.85%
3 months-41.52%
6 months-28.59%
Current year-58.01%
1 week 1.01
Extreme 1.01
1.61
1 month 1.01
Extreme 1.01
1.7
Current year 1.01
Extreme 1.01
4.4
1 year 1.01
Extreme 1.01
4.4
3 years 1.01
Extreme 1.01
6.3
5 years 1.01
Extreme 1.01
8.79
10 years 1.01
Extreme 1.01
10
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 64 16/10/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-14.65%-18.93%-36.18%-81.58% 56.69L
-0.22%-4.40%-19.63%+4.95% 18TCr
-1.56%-0.88%-0.08%+34.72% 12TCr
+0.19%-0.20%-11.51%+10.32% 12TCr
-1.80%-1.28%-42.47%+0.58% 9.11TCr
-0.64%-0.45%-3.69%+78.62% 6.65TCr
+0.31%+0.73%+12.35%-7.37% 5.89TCr
+1.19%-0.59%+4.22%+50.63% 5.5TCr
+0.38%-2.16%+3.38%+42.16% 4.89TCr
+0.48%+3.98%+3.60%-0.51% 3.55TCr
Average -1.57%-1.15%-9.00%+13.25% 8TCr
Weighted average by Cap. -0.27%-1.13%-10.01%+20.61%

Financials

2024 2025
Net sales 48.87L 64.22L 58.57L 54.15L 92.04L 60Cr 95.67L 6.54Cr 2.59Cr 32Cr 2.41Cr 2.36Cr 102.28Cr 37.56L 49.36L 45.01L 41.62L 70.74L 46Cr 73.53L 5.03Cr 1.99Cr 25Cr 1.85Cr 1.81Cr 79Cr
Net income -34.06L -44.76L -40.82L -37.74L -64.15L -42Cr -66.68L -4.56Cr -1.8Cr -23Cr -1.68Cr -1.64Cr -71Cr -30.61L -40.22L -36.68L -33.92L -57.65L -38Cr -59.92L -4.1Cr -1.62Cr -20Cr -1.51Cr -1.48Cr -64Cr
Net Debt 1.34Cr 1.76Cr 1.61Cr 1.48Cr 2.52Cr 164.47Cr 2.62Cr 18Cr 7.09Cr 89Cr 6.6Cr 6.46Cr 280.33Cr 1.5Cr 1.97Cr 1.8Cr 1.66Cr 2.82Cr 184.06Cr 2.93Cr 20Cr 7.93Cr 99Cr 7.39Cr 7.23Cr 313.71Cr
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
19/26/19 GBX 1.050 -14.65% 1,657
18/26/18 GBX 1.230 -10.87% 3,608
17/26/17 GBX 1.380 -1.43% 4,99,557
16/26/16 GBX 1.400 +2.94% 96,165
13/26/13 GBX 1.360 +5.02% 6,211